Skin & Soft Tissue Diseases

>

Latest News

FDA Approves VP-102 for Skin Virus That Affects Mostly Children
FDA Approves VP-102 for Skin Virus That Affects Mostly Children

July 22nd 2023

The federal agency gave the nod to Verrica Pharmaceuticals for its therapy, VP-102 (Ycanthe), for molluscum contagiosum (molluscum), making it the first treatment indicated for the viral-borne skin disease.

New York City Declares Mpox Outbreak Is Over
New York City Declares Mpox Outbreak Is Over

February 2nd 2023

World Neglected Tropical Diseases Day, Explained
World Neglected Tropical Diseases Day, Explained

January 30th 2023

Updates and Controversies in Necrotizing Soft Tissue Infections
Updates and Controversies in Necrotizing Soft Tissue Infections

December 28th 2022

Antiviral Drug Tecovirimat May Shorten Duration of Monkeypox Illness
Antiviral Drug Tecovirimat May Shorten Duration of Monkeypox Illness

June 8th 2022

Video Series
Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.